Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA reform health claims provision would "tie FDA's hands," CSPI's Silverglade says.

This article was originally published in The Tan Sheet

Executive Summary

FDA REFORM HEALTH CLAIMS PROVISION WOULD "TIE FDA's HANDS," CSPI Director of Legal Affairs Bruce Silverglade asserted at a July 7 Washington, D.C. press briefing on the Senate FDA reform bill (S 830) sponsored by Public Citizen, the Consumer Federation of America and the Patients' Coalition. Speaking for the Center for Science in the Public Interest, Silverglade maintained that, if passed as currently constructed, the FDA Modernization and Accountability Act would "tie FDA's hands and make it impossible for the agency to promptly prohibit misleading health claims on food labels."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087288

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel